Chill-Eze HB LT Part A

Maintenance

Revision date : 2024-09-23

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07 GHS08 GHS09
Health risk rating 4
Safety risk rating 3
Environmental risk rating 4

Note: Ingredients listed on restricted chemical lists

EC/CAS

14464-46-1

Name of the chemical

Cristobalit (s. u. TRGS 906)

Concentration

≥10

EC/CAS

500-033-5/25068-38-6

Name of the chemical

4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane

Concentration

≥10

Listed in

EC/CAS

271-846-8/68609-97-2

Name of the chemical

Oxirane, mono[(C12-14-alkyloxy)methyl] derivs

Concentration

≥2

Listed in

EC/CAS

236-675-5/13463-67-7

Name of the chemical

Reaction mass of titanium dioxide and silver chloride

Concentration

≥2

EC/CAS

202-859-9/100-51-6

Name of the chemical

Benzyl Alcohol

Concentration

≥2

General Information

Version

1.1

Revision date

2024-09-23

Product name

Chill-Eze HB LT Part A

Product name

Chill-Eze HB LT Part A

Identification on the label/Trade name

Product

1.2.1 Relevant identified uses

Industrial use,Professional use

supplier name

Maintenance

Icons in SDS

GHS07 GHS08 GHS09 M009 M010 M013 M017 T050

Company Information

company name

Maintenance

e-mail address of the competent person responsible for the Safety Data Sheet

sales@img-limited.co.uk

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H315, H317, H319, H332, H351, H372, H411

Hazard statements

Code

Statements

H315

Causes skin irritation

Section 2

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP)]

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (inhal.), Category 4 H332 Skin corrosion/irritation, Category 2 H315 Acute toxicity (inhal.), Category 4 H332 Serious eye damage/eye irritation, Category 2 H319 Skin corrosion/irritation, Category 2 H315 Skin sensitisation, Category 1 H317 Serious eye damage/eye irritation, Category 2 H319 Carcinogenicity, Category 2 H351 Skin sensitisation, Category 1 H317 Specific target organ toxicity – Repeated exposure, Category 1 H372 Carcinogenicity, Category 2 H351 Hazardous to the aquatic environment – Chronic Hazard, H411 Specific target organ toxicity – Repeated exposure, Category 1 H372 Category 2 Hazardous to the aquatic environment – Chronic Hazard, H411 Full text of H- and EUH-statements: see section 16 Category 2 Full text of H- and Adverse EUH-statements: physicochemical, see section human 16 health and environmental effects Adverse physicochemical, human health and environmental effects Suspected of causing cancer. Causes damage to organs through prolonged or repeated exposure. Harmful if inhaled. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. Toxic to aquatic life with long lasting effects. Suspected of causing cancer. Causes damage to organs through prolonged or repeated exposure. Harmful if inhaled. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. Toxic to aquatic life with long lasting effects. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP)

Adverse physicochemical, human health and environmental effects

Suspected of causing cancer. Causes damage to organs through prolonged or repeated exposure. Harmful if inhaled. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. Toxic to aquatic life with long lasting effects Suspected of causing cancer. Causes damage to organs through prolonged or repeated exposure. Harmful if inhaled. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. Toxic to aquatic life with long lasting effects

Hazard pictograms

GHS07 GHS08 GHS09

Signal word

Danger GHS07 GHS08 GHS09 Danger Dioxide

Contains

Cristobalite; Epoxy Polymer; Phenol-Formaldehyde Polymer; Alkyl Glycidyl Ether; Titanium Cristobalite; Epoxy Polymer; Phenol-Formaldehyde Polymer; Alkyl Glycidyl Ether; Titanium

Hazard statements

H315 - Causes skin irritation. Dioxide H317 - May cause an allergic skin reaction. H315 - Causes skin irritation. H319 - Causes serious eye irritation. H317 - May cause an allergic skin reaction. H332 - Harmful if inhaled. H319 - Causes serious eye irritation. 9/23/2024 (Revision date) H332 - Harmful if inhaled. GB - en 1/14 Revision: 1.1 9/23/2024 (Revision date) GB - en 1/14 H351 - Suspected of causing cancer. H372 - Causes damage to organs through prolonged or repeated exposure. H411 - Toxic to aquatic life with long lasting effects.

Precautionary statements

P201 - Obtain special instructions before use. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P308+P313 - IF exposed or concerned: Get medical advice/attention. P312 - Call a POISON CENTRE or doctor if you feel unwell. P314 - Get medical advice/attention if you feel unwell. P321 - Specific treatment (see supplemental first aid instruction on this label). P391 - Collect spillage.

Supplemental label elements

EUH205 - Contains epoxy constituents. May produce an allergic reaction. EUH211 - Warning! Hazardous respirable droplets may be formed when sprayed. Do not breathe spray or mist.

Additional information

Contains Pine oils.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.